Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / Apr / Two-Pronged Approach to POAG
Glaucoma

Two-Pronged Approach to POAG

A novel combined index of ssPERG and OCT could enhance early glaucoma detection, says retrospective cohort study:

By The Ophthalmologist 4/3/2025 2 min read

Share

0425-003-AI-news-Two-Pronged-POAG-Approach.png

Original images sourced from: Adobestock.com

A recent Ophthalmic Research study has introduced a new diagnostic approach for early primary open-angle glaucoma (POAG) by combining steady-state pattern electroretinogram (ssPERG) and optical coherence tomography (OCT) parameters. This innovative method significantly improves the early detection of retinal ganglion cell (RGC) dysfunction, potentially preventing irreversible vision loss caused by the disease.

Detecting glaucoma before noticeable vision impairment occurs is crucial, since significant RGC damage precedes VF changes. Traditional diagnostic methods like OCT provide structural analysis, while functional tests like ssPERG help to detect early RGC dysfunction. Employing these pre-existing modalities, the study evaluated whether combining the two methods could enhance diagnostic accuracy.

The retrospective cohort study included 135 eyes from 78 patients with early POAG and 57 healthy individuals. Researchers compared PERGratio, a measure derived from ssPERG, with various OCT and VF parameters, and found that: PERGratio alone had a high area under the receiver operating characteristic curve, marking it as one of the best functional indicators of early glaucoma; among OCT parameters, the 7 o’clock circumpapillary retinal nerve fiber layer (cpRNFL) thickness was effective at identifying early POAG; combining PERGratio with 7 o’clock cpRNFL thickness resulted in the highest diagnostic accuracy, outperforming all other combinations.

As with other previous glaucoma studies, the study supports the dysfunction-preceding-death hypothesis, which suggests that RGC dysfunction occurs before structural damage. Therefore, the combined index could act as a valuable tool for early glaucoma screening, helping ophthalmologists to detect the disease earlier before significant RGC loss and visual impairment occurs, improve their patient monitoring, and enhance diagnostic confidence by reducing reliance on subjective VF tests. However, the researchers do acknowledge challenges involved with implementing this combined modality into routine clinical practice due to the need for logistic regression calculations.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: